Varicella: historical perspective and clinical overview. 1996

T H Weller
Harvard School of Public Health, Boston, Massachusetts, USA.

In immunocompetent children in Europe and the United States, varicella is usually a benign disease. However, infants born to women who acquire varicella during or shortly after pregnancy are at high risk of infection. For unknown reasons, the disease is more severe in adolescents and adults, with pneumonia the most common cause of death. Varicella may also be lethal in patients of any age in the presence of biologic or iatrogenic immunosuppression. It is now well documented that varicella-zoster virus remains latent in the dorsal root and cranial ganglia following an attack of varicella. Viral reactivation appears with advancing age as cellular immunity wanes. The contemporary relative aging of the population will enhance the social significance of zoster. The immigration of nonimmune adults in temperate climates poses a major problem in terms of protection of high-risk children. A vaccination program is indicated.

UI MeSH Term Description Entries
D002644 Chickenpox A highly contagious infectious disease caused by the varicella-zoster virus (HERPESVIRUS 3, HUMAN). It usually affects children, is spread by direct contact or respiratory route via droplet nuclei, and is characterized by the appearance on the skin and mucous membranes of successive crops of typical pruritic vesicular lesions that are easily broken and become scabbed. Chickenpox is relatively benign in children, but may be complicated by pneumonia and encephalitis in adults. (From Dorland, 27th ed) Varicella,Chicken Pox
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014645 Herpesvirus 3, Human The type species of VARICELLOVIRUS causing CHICKENPOX (varicella) and HERPES ZOSTER (shingles) in humans. Chickenpox Virus,Herpes zoster Virus,Ocular Herpes zoster Virus,VZ Virus,Varicella-Zoster Virus,HHV-3,Herpesvirus 3 (alpha), Human,Herpesvirus Varicellae,Human Herpesvirus 3,Chickenpox Viruses,Herpes zoster Viruses,VZ Viruses,Varicella Zoster Virus,Varicella-Zoster Viruses,Varicellae, Herpesvirus
D016867 Immunocompromised Host A human or animal whose immunologic mechanism is deficient because of an immunodeficiency disorder or other disease or as the result of the administration of immunosuppressive drugs or radiation. Immunosuppressed Host,Immunocompromised Patient,Host, Immunocompromised,Host, Immunosuppressed,Hosts, Immunocompromised,Hosts, Immunosuppressed,Immunocompromised Hosts,Immunocompromised Patients,Immunosuppressed Hosts,Patient, Immunocompromised,Patients, Immunocompromised

Related Publications

T H Weller
January 2014, Sub-cellular biochemistry,
T H Weller
July 1996, Journal of neuro-oncology,
T H Weller
January 1994, International journal of radiation biology,
T H Weller
April 2007, The American journal of the medical sciences,
T H Weller
January 1982, Methods in cell biology,
T H Weller
August 1983, Annals of allergy,
T H Weller
June 2006, Infectious disease clinics of North America,
T H Weller
November 2004, The American journal of medicine,
T H Weller
June 1999, Chemico-biological interactions,
T H Weller
March 1999, Journal of clinical pharmacology,
Copied contents to your clipboard!